Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
2020 ◽
Vol 127
◽
pp. 173-182
◽
Keyword(s):
Phase Ii
◽